A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Fruquintinib
Related studies linked through entity extraction aliases.
Fruquintinib Hepatic Impairment Study
- Status
- COMPLETED
- Phase
- PHASE1
Fruquintinib Renal Impairment Study
- Status
- COMPLETED
- Phase
- PHASE1
Fruquintinib in the Treatment of Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC）
- Status
- COMPLETED
- Phase
- PHASE2
The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Fruquintinib CYP3A Inhibitor and Inducer Study
- Status
- COMPLETED
- Phase
- PHASE1
Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Fruquintinib as a Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study to Evaluate the Efficacy and Safety of Fruquintinib Plus Sintilimab as Third-line Therapy for Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2